Professionals 203 Users Online

Gamma Vitamin E Supplement

The Rise in the Prevalence of Cancer and Cardiovascular Diseases to Augment the Demand for Gamma Vitamin E Supplements: Opportunities Ahead

Gamma Vitamin E Supplement Market by Form (Soft Gels, Capsule, Tablets, Gummies, Powder), The Form of Tablets are Projected to Grow at a CAGR of 5.2% from 2023 to 2033.

Gamma Vitamin E Supplement Market Snapshot

Newly-released Gamma Vitamin E Supplement analysis report by Persistence Market Research reveals that global sales of Gamma Vitamin E Supplement in 2022 were held at US$ 2.1 Billion. With a 5.3% projected CAGR from 2023 to 2033, the market is expected to reach a valuation of US$ 3.7 Billion by the end of the forecast period.

Gamma Vitamin E supplements in the form of tablets are expected to be the significant revenue-generating type and are projected to grow at a CAGR of over 5.2% from 2023 to 2033.

Attributes

Details

Gamma Vitamin E Supplement Market (2023)

US$ 2.2 Billion

Gamma Vitamin E Supplement Market (2033)

US$ 3.7 Billion

Gamma Vitamin E Supplement CAGR (2018 to 2022)

6.2%

U.S Gamma Vitamin E Supplement CAGR (2023 to 2033)

4.2%

Key Companies Covered

  • Glanbia Plc.
  • Pfizer Inc.
  • Bayer AG
  • Amway Corp.
  • GlaxoSmithKline Plc.
  • Good Health New Zealand
  • The Nature's Bounty Co.
  • NOW Foods
  • Abbott
  • Herbalife Nutrition
Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Revenue of Gamma Vitamin E Supplement from 2022 Compared to Demand Outlook for 2023 to 2033

As per the Gamma Vitamin E Supplement Research By Persistence Market Research - a market research and competitive intelligence provider, historically, from 2018 to 2022, the value of Gamma Vitamin E Supplement increased by around 6.2% CAGR. With an absolute dollar opportunity of US$ 1.5 Billion during the forecast period, the market is projected to reach a US$ 3.7 Billion valuation by 2033.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Which Factors are Influencing the Gamma Vitamin E Supplement Industry’s Expansion?

Cancer as well as cardiovascular diseases remain the top causes of death globally. According to WHO, around, 18 million people died due to cardiovascular diseases which comprised about 31% of the global mortality rate. The World Heart Federation predicts around 22 million deaths will be affected by cardiovascular disease by 2030. Cancer also has a high incidence rate and according to the national cancer institute there were around 18 million new cases and 9.5 million deaths due to cancer in 2018. This number is projected to increase to around 28 million new cases and 15 million deaths by 2040.

Gamma Vitamin E helps in lowering the bad cholesterol within the body, which reduces the risk of an individual having a stroke or any cardiovascular disease such as coronary heart disease. The anti-inflammatory properties of gamma vitamin E can help reduce inflammation in people suffering from illnesses like rheumatoid arthritis, and asthma.

Growing consumer awareness of the importance of living a healthy lifestyle has expanded the Gamma Vitamin E supplement Market. Along with the rise in the geriatric population, there also has been a significant increase in the incidence of chronic illnesses such as asthma and rheumatoid arthritis as well as cardiovascular diseases and cancer. The research conducted in recent years has been able to establish that gamma vitamin E possesses anti-inflammatory and anti-cancer properties as well as can reduce the risk of cardiovascular diseases.

The rise in the incidence of chronic illness and cardiovascular diseases along with the rise in the popularity of supplements are projected to expand the market during the assessment period.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

Which Region is Projected to Offer Significant Gamma Vitamin Supplements?

North America had a Gamma Vitamin E Supplement size of over US$ 850 Million in 2022 and is estimated to cross US$ 900 Million by 2023. It is projected that North America will have a Gamma Vitamin E supplement worth US$ 1.5 Billion in 2033. The historical CAGR between 2018 and 2022 is 33%. The regional market is forecasted to witness a CAGR of 5.3% from 2023 to 2033.

North America has a significant rate of incidences of cancer and cardiovascular diseases among its population. It is one of the leading causes of death in the region. Along with cancer cardiovascular diseases such as coronary artery disease also claim many lives each year in the region. Around 2.5 million adults in the North American region were diagnosed with cancer in 2020. Centers for Disease Control and Prevention (CDC) estimates that one person dies in the United States every 34 seconds due to some form of heart disease. The cause of high incidences of cancer and cardiovascular diseases can be attributed to unhealthy lifestyles and excessive alcohol use. The market for gamma vitamin E supplements is projected to expand during the assessment period due to an increase in awareness about the benefits of supplements on health and consumers looking forward to improving their health using the supplements.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Country-wise Analysis:

United States of America Gamma Vitamin E Supplement Market Analysis:

The market in the United States is expected to grow to be worth US$ 1.2 Billion by 2033, registering an absolute dollar growth of US$ 397.7 Million between 2023 and 2033. The Gamma Vitamin E Supplement in the United States has grown at a CAGR of 4.7% from 2018 to 2022 and is expected to grow at a CAGR of 4.2%.

Heart disease is one of the predominant causes of death in the United States. According to the CDC, around 697,000 adults in the United States lost their life due to heart disease in the year 2020. Coronary artery disease is the most common type of heart disease. According to the CDC, around 382,000 adults lost their life due to coronary artery disease.

According to research conducted recently, the number of deaths due to heart disease will increase by around 18% by 2030. With the increase in the number of people being affected by heart disease and the rise in the popularity of supplements among the population, the market is projected to expand during the assessment period.

U.K. Gamma Vitamin E Supplement Market Analysis:

The market in the U.K. is expected to grow to be worth US$ 181.4 Million by 2033, reaching an absolute dollar growth of US$ 64.3 Million from 2023 to 2033. The market in the U.K. has grown at a CAGR of 5% from 2018 to 2022 and is expected to grow at a CAGR of 4.5%.

The U.K. has a high prevalence of cancer among its population. According to McMillan Cancer Support, around 3 million people were diagnosed with cancer in 2022 and this number is projected to reach 4 million by 2030 whereas the number of deaths stood at 147,000 in 2020 due to cancer. Owing to these statistics, the market is projected to expand in the country during the assessment period.

Japan Gamma Vitamin E Supplement Market Analysis:

The market in Japan is expected to grow to be worth US$ 269.8 Million by 2033, with an absolute dollar growth of US$ 99.9 Million from 2023 to 2033. The market in Japan has grown at a CAGR of 5.4% from 2018 to 2022 and is expected to grow at a CAGR of 4.7%.

Japan is considered to be a nation with a significant life expectancy. Recently there has been a rise in the geriatric population in Japan which has given rise to high incidences of diseases such as cancer, cardiovascular diseases such as coronary artery disease, and chronic illness such as rheumatoid arthritis. According to the cancer registry of Japan Ganjoho. jp, around 1.1 million adults were diagnosed with cancer, and around 380,000 deaths were due to cancer.

The rise in the geriatric population and illnesses like cardiovascular diseases and chronic illnesses like rheumatoid arthritis provides a lucrative opportunity for the market to expand in Japan.

China Gamma Vitamin E Supplement Market Analysis:

The market in China is expected to grow to be worth US$ 319.3 with an absolute dollar growth of US$ 145.3 Million till 2033. The market in China has grown at a CAGR of 7.7% from 2018 to 2022 and is expected to grow at a CAGR of 6.3% from 2023 to 2033.

According to the International Agency for Research on Cancer, around 4.5 million people in China have been diagnosed with cancer. By 2030, it is projected that around 5.8 million adults would be affected by cancer. Around 3 million deaths in the country were attributed to cancer and it is projected that the mortality from cancer would be around 1 million adults by 2030.

Owing to these alarming statistics, consumers in China are inclined to consume supplements including Gamma Vitamin E Supplements, to prevent such ailments.

South Korean Gamma Vitamin E Supplement Market Analysis:

The market in South Korea is expected to grow to be worth US$ 150.5 Million by 2033, grossing an absolute dollar growth of US$ 63.9 Million till 2033. The Gamma Vitamin E Supplement in South Korea has grown at a CAGR of 6.9% from 2018 to 2022 and is expected to grow at a CAGR of 5.7% from 2023 to 2033.

According to the WHO reports, around 230,000 adults were diagnosed with cancer in 2020 and the number of people affected by cancer is projected to rise to about 296,000 adults. Around 88000 deaths were attributed to cancer and it is projected to reach 129,000 deaths due to cancer in 2030.

The rise in the number of non-communicable illnesses such as cancer and cardiovascular diseases in South Korea can be attributed to the rise in the geriatric population of the country. In recent years, there has been a rise in awareness about the health benefits of consuming supplements in South Korea, which is projected to expand the market in the country.

Category-wise Insights

Which Form of Gamma Vitamin E Supplement is projected to Witness Significant Growth?

Gamma Vitamin E Supplement in the form of Tablets is projected to witness significant growth as it has grown at a CAGR of 6% from 2018 to 2022 and is expected to grow at a CAGR of 5.2% from 2023 to 2033.

Tablets are the preferred form of Gamma Vitamin E Supplement among the population. People prefer vitamin supplements in the form of tablets as its cost-effective as well as offer a significant shelf life.

Which distribution channel of Gamma Vitamin E Supplement is Expected to be Most Lucrative?

The market through offline sales channel is projected to witness prominent growth as it has grown at a CAGR of 5.8% from 2018 to 2022 and is expected to grow at a CAGR of 5.1% from 2023 to 2033.

The market through offline sales is projected to expand significantly during the assessment period due to the rise in the popularity of supplements among the population. Offline sales channel includes retail shops or pharmacies. People prefer to buy supplements from retail stores such as pharmacies because they are able to check the quality and type of supplement that they wish to buy.

Buying supplements do not require a prescription. Another reason that consumers prefer to buy from retail stores is that they can ask the salesperson questions regarding the product, therefore, allowing them to make a better decision.

Competitive Analysis:

The players in the market are currently investing heavily in research to gain more information regarding the health benefits of gamma vitamin E supplements and their long-term benefits on human health. The manufacturers are also developing better formulations of gamma vitamin E supplements to provide maximum benefit for consumers.

The key players in the market include Glanbia Plc, Pfizer Inc., Bayer AG, Amway Corp., GlaxoSmithKline plc, Good Health New Zealand, The Nature's Bounty Co., NOW Foods, Abbott, and Herbalife Nutrition.

A few of the recent developments are:

  • In April 2021, Nestle acquired nature’s bounty for US$ 5.7 Billion to expand its Vitamin Supplement portfolio.

Segmentation of the Global Gamma Vitamin E Supplements:

By Form

  • Tablet
  • Soft gels
  • Capsule
  • Powder
  • Gummies

By Sales Channels

  • Online Sales
  • Offline Sales

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

- Companies Covered in This Report -

  • Glanbia Plc
  • Pfizer Inc.
  • Bayer AG
  • Amway Corp.
  • GlaxoSmithKline plc
  • Good Health New Zealand
  • The Nature's Bounty Co.
  • NOW Foods
  • Abbott
  • Herbalife Nutrition

- Frequently Asked Questions -

The global market was worth US$ 2.1 Billion in 2022.

The global market is projected to witness a market size of US$ 2.2 Billion in 2023.

The market is projected to reach US$ 3.7 Billion by 2033.

The CAGR growth of the Gamma Vitamin E Supplement over the last 4 years is 6.2%.

The projected CAGR for Gamma Vitamin E Supplement is 5.3%.

The retail sales channel of Gamma Vitamin E Supplement will garner a significant value share by 2023.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate